dgn-np:NP66136.RAFnuUA8S4vZbtYXQA8HcnArdGn5q1BQobtZ3QvtWjmPg130_provenance {
  dgn-np:NP66136.RAFnuUA8S4vZbtYXQA8HcnArdGn5q1BQobtZ3QvtWjmPg130_assertion dcterms:description "[Previous studies have identified a single-nucleotide polymorphism in the gene encoding peroxisome proliferator-activated receptor-delta (PPARD), rs2016520, that is associated with changes in metabolic disease in some but not all studies, which suggests that PPARD agonists may have therapeutic benefits for the treatment of metabolic disorders, including dyslipidemia, type 2 diabetes, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ;
    wi:evidence dgn-void:source_evidence_literature ;
    sio:SIO_000772 miriam-pubmed:20200337 ;
    prov:wasDerivedFrom dgn-void:gad-20150221 ;
    prov:wasGeneratedBy eco:ECO_0000203 .
  dgn-void:gad-20150221 pav:importedOn "2015-02-21"^^xsd:date .
  dgn-void:source_evidence_literature a eco:ECO_0000212 ;
    rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ;
    rdfs:label "DisGeNET evidence - LITERATURE"@en .
}